Research use only · EU-warehoused · COA on every batch · HPLC ≥99% · Shipment 2–5 days
Log in Register
Home/ Catalogue/ Peptides in Vials/ TB-500
In stock
TB-500

TB-500

Lyophilised · ≥99% (HPLC) ·

Quantity Volume discounts auto-applied
Custom quantity
1
Shipping to EuropeDispatched from our EU facility in Slovakia, so EU destinations clear no third-country customs. Packeta, DPD or DHL Express depending on country — handling 1–2 business days; typical transit is 1 day in Slovakia, about 2 days to CZ/AT/HU/PL/DE, 1–3 days elsewhere in the EU/EEA, and 2–4 days to non-EU Europe plus local customs. Shipping is calculated at checkout and VAT is shown before you pay.

Supplied lyophilised. Reconstitution typically uses bacteriostatic water.

How to reconstitute TB-500 — stock calculator
Independently third-party tested · COA on every batch · 48h EU dispatch
[01]

Overview

TB-500 is synthetic full-length thymosin beta-4: the complete 43-amino-acid, N-terminally acetylated actin-sequestering protein (CAS 77591-33-4), studied in cell-migration, angiogenesis and tissue-repair models. Supplied as thymosin beta-4 acetate (the acetate salt), a sterile lyophilised peptide, at ≥99% purity by reversed-phase HPLC in a 10 mg vial. It is not the 7-residue Ac-LKKTETQ fragment, which Condor Research lists separately as TB-500 (Frag). For laboratory research use only; not for human or veterinary use.

Reproducing a peptide the body produces naturally, TB-500 here is the full synthetic sequence of thymosin β4 — a 43-residue actin-binding peptide expressed across human tissues. It is one of the most widely studied molecules in cell-migration and tissue-repair research, valued in the laboratory for its solubility and for matching the sequence of a well-characterised native protein.

The whole developmental peptide, not a fragment. Thymosin β4 is a naturally occurring actin-sequestering peptide whose expression has been mapped across many human organs during development (Faa et al., 2024). Because TB-500 carries the complete sequence — from the N-terminal Ac-SDKP region to the central actin-binding motif at residues 17–23 — it lets researchers study the intact molecule rather than isolated sub-sequences.

What the research explores. Rather than a single pathway, thymosin β4 — and, in some studies, peptides derived from it — is investigated across several intersecting themes:

  • Wound healing & cell migration — studied in corneal- and skin-repair models and microneedle-delivery systems (Nguyen et al., 2025; He et al., 2026).
  • Cardiac & vascular repair — examined for effects on ischemic cardiac dysfunction and hypoxic microvascular endothelial stability (Zhang et al., 2025; Stewart et al., 2025).
  • Renal & neurological signalling — explored in glomerular pathophysiology and in neuroinflammation/neurite models, the latter with Tβ4-derived peptides (Mason et al., 2023; Ou et al., 2026).

The findings outlined here come from in-vitro and animal studies; they characterise biological activity under laboratory conditions and do not establish efficacy or safety in humans. Full citations are listed under the Scientific References tab.

Which “TB-500” is which. The name is used in the market for more than one molecule; sequence, mass and CAS number, not the trade name, identify what is in the vial.

Condor Research product Molecule Sequence Length MW (g/mol) CAS
TB-500 (Frag); TB-500 Capsules; the TB-500 in BPC-157 + TB-500, GLOW, KLOW and BPC-157 Arginate + TB-500 Capsules Thymosin β4 fragment 17–23, N-acetylated Ac-LKKTETQ 7 aa 889.0 885340-08-9
TB-500 (10 mg vial) Full-length thymosin β4 Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES 43 aa 4963.44 77591-33-4
Not listed by Condor Research Thymosin β4 fragment 1–4 (goralatide) Ac-SDKP 4 aa 487.5 120081-14-3

Physicochemical profile. CAS No. 77591-33-4 · Molecular formula C212H350N56O78S · Molecular weight 4963.44 g/mol · Sequence Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser · Appearance: white lyophilized powder · Solubility: soluble in water at 1 mg/mL.

Specification & quality. Each individually sealed vial contains 10 mg of TB-500 as a white lyophilized powder at ≥99% purity by HPLC. Every batch is third-party tested, and a Certificate of Analysis (COA) is available. Store at −20 °C, protected from light and moisture; shelf life 24 months from the manufacture date.

This product is intended for laboratory research use only (RUO). It is not a drug, food, cosmetic, or dietary supplement, and is not for human or veterinary use, ingestion, or diagnostic application. Handling is restricted to qualified research professionals operating in an appropriately equipped laboratory.

Supplied for in-vitro laboratory research use only (RUO). Not a drug, food or supplement; not for human or veterinary use.

[04]

Quality & COA

Certificate of Analysis
Lot-specific COA with every order

Certificate of Analysis — lot-specific COA ships with every order and is available on request.

Each lot is tested by an independent third-party laboratory for identity (mass spectrometry) and purity (HPLC). The Certificate of Analysis for your specific batch ships with the order and is available on request — no house data, no exceptions.

HPLC purity
≥99% (HPLC)
Method
HPLC + MS
Endotoxin
Reported
[02]

Data Sheet

CAS number77591-33-4
Molecular formulaC212H350N56O78S
Molecular weight4963.44
SequenceAc-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser
Purity≥99% (HPLC)
Physical formWhite lyophilized powder
Quantity10mg/vial
SolubilitySoluble in water at 1mg/mL
StorageStore at -20°C, protect from light
ReconstitutionReconstitute with bacteriostatic water or sterile saline.
Shelf life24 months from manufacture date
OriginEU · Slovakia
ClassificationResearch use only
[03]

Scientific References

01 Di H, Huang J, Zhang D, Ni F, Zheng R, Geng H. Thymosin beta 4: An emerging therapeutic candidate for kidney diseases. Peptides. 2026;195:171467. PMID: 41570941. doi:10.1016/j.peptides.2026.171467. PubMed 02 Faa G, Messana I, Coni P, Piras M, Pichiri G, Piludu M, et al. Thymosin β(4) and β(10) Expression in Human Organs during Development: A Review. Cells. 2024;13(13). PMID: 38994967. doi:10.3390/cells13131115. PubMed 03 Mason WJ, Vasilopoulou E. The Pathophysiological Role of Thymosin β4 in the Kidney Glomerulus. Int J Mol Sci. 2023;24(9). PMID: 37175390. doi:10.3390/ijms24097684. PubMed 04 Naeem A, Knoer G, Avantaggiati ML, Rodriguez O, Albanese C. Provocative non-canonical roles of p53 and AKT signaling: A role for Thymosin β4 in medulloblastoma. Int Immunopharmacol. 2023;116:109785. PMID: 36720193. doi:10.1016/j.intimp.2023.109785. PubMed 05 Xing Y, Ye Y, Zuo H, Li Y. Progress on the Function and Application of Thymosin β4. Front Endocrinol (Lausanne). 2021;12:767785. PMID: 34992578. doi:10.3389/fendo.2021.767785. PubMed 06 Wang Y, Carion TW, Ebrahim AS, Sosne G, Berger EA. Adjunctive Thymosin Beta-4 Treatment Influences PMN Effector Cell Function during Pseudomonas aeruginosa-Induced Corneal Infection. Cells. 2021;10(12). PMID: 34944086. doi:10.3390/cells10123579. PubMed 07 He S, Yuan M, Feng C, Zhang Y, Che J. Low-Temperature Fabrication of Thymosin β4-Loaded Soluble Microneedles to Promote Wound Healing by Specific Binding to Downregulated Immune Regulators Vsig4 and IL22rɑ2. Adv Healthc Mater. 2026;15(12):e04878. PMID: 41467542. doi:10.1002/adhm.202504878. PubMed 08 Lachowicz JI, Congiu T, Salis A, Cesare Marincola F. Zinc Coordination by Thymosin β4: Structural Determinants and Functional Implications. Int J Mol Sci. 2026;27(4). PMID: 41751875. doi:10.3390/ijms27041740. PubMed 09 Ou H, Chen R, Zhou L, Zhang Y, Zhao S, Yang Z. Thymosin β4-derived peptides alleviate neuroinflammation and neurite atrophy in both in vitro models and in vivo 5 × FAD mice: A potential therapy for memory improvement in Alzheimer's disease. Int Immunopharmacol. 2026;170:116097. PMID: 41443105. doi:10.1016/j.intimp.2025.116097. PubMed 10 Zhang Y, Dong Q, Bian X, Qiao Z, Cui C, Yang N, et al. Recombinant human thymosin beta 4 improves ischemic cardiac dysfunction in mice and patients with acute ST-segment elevation myocardial infarction after reperfusion. Cardiovasc Res. 2025;121(17):2747-2758. PMID: 41229390. doi:10.1093/cvr/cvaf223. PubMed 11 Stewart WG, Hejl CD, Guleria RS, Gupta S. Thymosin β4 stabilizes hypoxia induced brain microvascular endothelial cell dysfunction through S1PR1 dependent mechanisms. Sci Rep. 2025;15(1):45764. PMID: 41326489. doi:10.1038/s41598-025-28435-2. PubMed 12 Sun YS, Bai XQ, Sun KD, Li J, Liu L, Chen YY, et al. Thymosin β4 released by mast cells under stress conditions impairs intestinal epithelial barrier via IL22RA1/JAK1/STAT3 signaling in irritable bowel syndrome. World J Gastroenterol. 2025;31(42):111706. PMID: 41278163. doi:10.3748/wjg.v31.i42.111706. PubMed 13 Nguyen J, Verma S, Vuong VT, Queener H, Coulson-Thomas VJ, Gesteira TF. Engineered Tandem Thymosin Peptide Promotes Corneal Wound Healing. Invest Ophthalmol Vis Sci. 2025;66(14):31. PMID: 41235866. doi:10.1167/iovs.66.14.31. PubMed 14 Zeng PM, Sun XY, Li Y, Wu WD, Huang J, Cao DD, et al. Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids. Stem Cell Reports. 2025;20(9):102601. PMID: 40816274. doi:10.1016/j.stemcr.2025.102601. PubMed 15 Wu J, Yang P, Zhang J, Chen Z, Wei Y, Su Y, et al. Association Between Thymosin β4 and Coronary Arterial Lesions in Children with Kawasaki Disease. J Inflamm Res. 2025;18:8755-8765. PMID: 40631047. doi:10.2147/JIR.S519589. PubMed

References are illustrative of the research literature surrounding this compound. All claims relate to in-vitro and animal models only.

[05]

FAQ

TB-500 is a synthetic peptide based on thymosin beta-4, a 43-residue actin-binding peptide the body expresses across many tissues. It is widely studied in regenerative, cell-migration and tissue-repair research. Condor supplies it strictly as a Research Use Only reference compound for in vitro and animal studies, not for human or veterinary use.

TB-500 is a large peptide (43 residues, MW ~4963) based on thymosin beta-4, studied for actin binding and cell migration. BPC-157 is a small 15-amino-acid peptide derived from a gastric protein, studied for cytoprotection. They act through different mechanisms, so both are used as distinct tissue-repair reagents. Research use only.

TB-500 is full-length synthetic thymosin beta-4 (43 residues, MW 4963.44, CAS 77591-33-4; 10 mg/vial). TB-500 (Frag) is Ac-LKKTETQ, the acetylated 7-residue sequence from residues 17–23 — the central actin-binding motif (MW 889.0, CAS 885340-08-9; 2 mg/vial). They are different molecules, not two strengths of one. Choose the full peptide or the fragment depending on whether your research targets the intact protein or that motif. Research use only.

This TB-500 is the full thymosin beta-4-based peptide: 43 residues, molecular formula C212H350N56O78S, MW 4963.44 (CAS 77591-33-4). The separately listed TB-500 (Frag) product is the 7-residue Ac-LKKTETQ fragment (thymosin beta-4 residues 17–23), and TB-500 Capsules contain that same fragment. Identity and purity (>=99%) are confirmed by HPLC on each batch, documented in the lot Certificate of Analysis.

No. The TB-500 component in GLOW, KLOW and the BPC-157 + TB-500 blend is the 7-residue fragment Ac-LKKTETQ (thymosin beta-4 residues 17–23, CAS 885340-08-9), the same molecule as TB-500 (Frag) — not the full-length 43-residue thymosin beta-4 in this 10 mg vial. Choose this standalone vial to study the intact protein, or a blend to investigate the fragment alongside BPC-157 and GHK-Cu. Research use only.

Yes. Condor Research supplies TB-500 strictly as a Research Use Only (in vitro) reference compound to professionals and institutions, not as a medicine, supplement or product for human or veterinary use. Buyers are responsible for confirming import legality in their own country. Questions: info@condorresearch.com.

Yes. Every TB-500 batch is tested by an independent third-party laboratory by HPLC for identity and purity (>=99%), with mass spectrometry confirmation of this large peptide, and ships with a lot-specific Certificate of Analysis. To request the COA before ordering, contact info@condorresearch.com.

For laboratory preparation, TB-500 is reconstituted in water (listed solubility 1 mg/mL); adding 10 mL of bacteriostatic water to the 10 mg vial gives 1 mg/mL. Store the sealed vial at -20C, protected from light; shelf life is 24 months. For in vitro and animal research only, never human or veterinary use.

Lyophilized TB-500 is stable for short room-temperature transit, so cold packs are generally not required for shipping; brief delivery times within Europe do not compromise the powder. On arrival, store the sealed vial at -20C, protected from light, for long-term stability. Questions: info@condorresearch.com.

If a vial arrives damaged or non-conforming, notify info@condorresearch.com ideally within 48 hours with photos, and a replacement, reshipment or store credit can be arranged. Each batch is independently HPLC-tested at >=99% with a Certificate of Analysis backing the stated purity. Sealed laboratory goods are otherwise final sale (B2B).

Condor Research supplies TB-500 directly, dispatched from our EU facility in Slovakia to the EU, EEA, UK and Switzerland. Deliveries to EU destinations clear no third-country customs, and shipping is calculated at checkout. Supplied strictly as a research-use-only reference material — not for human or veterinary use.

[06]

Reviews

Leave a review
Earn 250 points for a verified review (account required).

No verified reviews yet.

Leave a review

Related compounds

Tissue repair

BPC-157

5 mg, lyophilised≥99% HPLC
€39.99€35.99 each from 10
Skin & regenerative

GHK-Cu

50 mg, lyophilised≥99% HPLC
€39.99€35.99 each from 10
Tissue repair

TB-500 Capsules

60 capsules × 500 mcg≥99% HPLC
€164.90€148.41 each from 10
Blends

BPC-157 + TB-500

20 mg, 2-peptide blend≥99% HPLC
€119.99€107.99 each from 10